Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | I-97-007 |
Topic: | Radium Ra 223 Dichloride for Treatment of Prostate Cancer |
Section: | Injections |
Effective Date: | July 30, 2018 |
Issue Date: | July 30, 2018 |
Last Reviewed: | June 2018 |
Archived July 30, 2018 This policy Radium Ra 223 Dichloride for Treatment of Prostate Cancer has been archived as of 7/30/2018 and is no longer in effect. For services rendered prior to the archived date of this policy, please refer to prior versions of the policy. For services rendered after the archived date of this policy, please refer to R-65 Radiation Therapy for Bone Metastases.
|
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
.
The policy position applies to all commercial lines of business |
Denial Statements |
Links |